当前位置:首页 - 行情中心 - 恒瑞医药(600276) - 财务分析 - 现金流量表

恒瑞医药

(600276)

  

流通市值:3344.51亿  总市值:3479.88亿
流通股本:63.79亿   总股本:66.37亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金6,671,724,436.3633,605,876,222.7426,173,262,016.0415,666,363,464.51
  收到其他与经营活动有关的现金252,626,908.491,228,283,666.84799,560,767.34457,430,575.96
  经营活动现金流入小计6,924,351,344.8534,834,159,889.5826,972,822,783.3816,123,794,040.47
  购买商品、接受劳务支付的现金379,189,175.22,099,963,151.921,167,102,744.63910,938,758.61
  支付给职工以及为职工支付的现金2,166,754,419.697,004,960,838.625,462,509,586.423,558,646,926.64
  支付的各项税费698,501,493.042,787,135,744.231,839,015,825.491,367,794,099.13
  支付其他与经营活动有关的现金2,893,460,356.2111,706,722,024.189,393,764,336.575,985,961,004.69
  经营活动现金流出小计6,137,905,444.1423,598,781,758.9517,862,392,493.1111,823,340,789.07
  经营活动产生的现金流量净额786,445,900.7111,235,378,130.639,110,430,290.274,300,453,251.4
二、投资活动产生的现金流量:
  收回投资收到的现金-151,000,000151,000,000150,000,000
  取得投资收益收到的现金518,588.5151,492,129.4430,047,582.8829,112,592.22
  处置固定资产、无形资产和其他长期资产收回的现金净额10,854,350.5518,911,785.277,147,978.593,719,423.42
  投资活动现金流入小计11,372,939.06221,403,914.71188,195,561.47182,832,015.64
  购建固定资产、无形资产和其他长期资产支付的现金704,818,964.872,961,906,284.581,714,462,484.691,267,564,947.42
  投资支付的现金30,300,000---
  投资活动现金流出小计735,118,964.872,961,906,284.581,714,462,484.691,267,564,947.42
  投资活动产生的现金流量净额-723,746,025.81-2,740,502,369.87-1,526,266,923.22-1,084,732,931.78
三、筹资活动产生的现金流量:
  吸收投资收到的现金-10,351,937,892.2810,351,937,892.2810,351,937,892.28
  取得借款收到的现金299,534,222.251,495,572,622.12428,335,302.78-
  收到其他与筹资活动有关的现金-418,168,545--
  筹资活动现金流入小计299,534,222.2512,265,679,059.410,780,273,195.0610,351,937,892.28
  偿还债务支付的现金300,000,0001,500,000,000--
  分配股利、利润或偿付利息支付的现金-1,284,255,700.451,274,130,192.81,274,130,192.8
  支付其他与筹资活动有关的现金185,251,178.591,699,715,987.251,415,122,611.081,038,312,699.07
  筹资活动现金流出小计485,251,178.594,483,971,687.72,689,252,803.882,312,442,891.87
  筹资活动产生的现金流量净额-185,716,956.347,781,707,371.78,091,020,391.188,039,495,000.41
四、汇率变动对现金及现金等价物的影响-349,701,516.56-360,132,552.71-146,577,748.5848,287,663.47
五、现金及现金等价物净增加额-472,718,59815,916,450,579.7515,528,606,009.6511,303,502,983.5
  加:期初现金及现金等价物余额40,155,552,697.4124,239,102,117.6624,239,102,117.6624,239,102,117.66
  期末现金及现金等价物余额39,682,834,099.4140,155,552,697.4139,767,708,127.3135,542,605,101.16
补充资料:
  净利润-7,717,002,245.78-4,454,670,657.21
  资产减值准备-86,914,039.97-9,443,508.19
  固定资产和投资性房地产折旧-689,203,837.11-347,244,043.34
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-689,203,837.11-347,244,043.34
  无形资产摊销-114,581,839.37-52,108,856.42
  长期待摊费用摊销-97,702,799.02-43,231,966.88
  处置固定资产、无形资产和其他长期资产的损失--4,053,134.77--2,311,106.15
  固定资产报废损失-3,289,843.5-1,875,878.05
  公允价值变动损失--173,573,838.21--111,263,854.42
  财务费用-374,481,650.12--36,624,580.62
  投资损失-57,480,679.6-12,354,120.47
  递延所得税--403,931,406.24--21,405,272.89
  其中:递延所得税资产减少--403,782,268.44--32,699,770.72
    递延所得税负债增加--149,137.8-11,294,497.83
  存货的减少--479,237,472.88--173,390,260.24
  经营性应收项目的减少--1,097,175,061.93--691,831,578.87
  经营性应付项目的增加-4,134,810,119.38-280,027,724.23
  其他-53,018,404.41-126,931,999.62
  现金的期末余额-40,155,552,697.41-35,542,605,101.16
  减:现金的期初余额-24,239,102,117.66-24,239,102,117.66
  现金及现金等价物的净增加额-15,916,450,579.75-11,303,502,983.5
公告日期2026-04-232026-03-262025-10-282025-08-21
审计意见(境内)标准无保留意见
TOP↑